Chinese hawthorn is an East Asian tree's red fruit, eaten as food and used in Chinese medicine for digestion, cholesterol and blood pressure. Species-specific evidence is thin; it is an inexpensive dietary addition with plausible but largely unproven heart and metabolic benefits. Safety is generally reassuring at food and supplement amounts, though large amounts of fresh fruit can form bowel-blocking masses; reports tie it to excessive anti-clotting effects with warfarin. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | <100 mg/dL | Expected to change |
| Triglycerides | <150 mg/dL | Expected to change |
| Blood pressure (home) | <120/80 mmHg | Expected to change; safety check for low readings |
| ALT | Approximately 7–56 U/L | Expected to change in fatty liver |
| Digoxin level (if prescribed) | No established target; track change from own baseline on an unaffected assay | Safety check |
| INR (if taking warfarin) | No established target for hawthorn users; track change from own baseline within the prescriber's therapeutic range | Safety check |
| Body weight | Not specified in the ER | Body-composition baseline |
| Waist circumference | Not specified in the ER | Body-composition baseline |
| Total cholesterol | Not specified in the ER | Paired with LDL |
| HDL | Not specified in the ER | Paired with LDL |
| AST | Not specified in the ER | Paired with ALT |
| GGT | Not specified in the ER | Paired with ALT |
Cadence: Baseline before starting; lipid panel and liver enzymes typically at 8–12 weeks, then every 6–12 months; home blood pressure twice weekly for the first 4 weeks, then monthly; INR within 1–2 weeks of starting for warfarin users